Cytokinetics Operating Cycle from 2010 to 2026
| CYTK Stock | USD 63.36 1.02 1.64% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 378.31 | Current Value 297.25 | Quarterly Volatility 147.5563994 |
Check Cytokinetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytokinetics' main balance sheet or income statement drivers, such as Interest Expense of 104.5 M, Other Operating Expenses of 669.8 M or Research Development of 409.8 M, as well as many indicators such as Price To Sales Ratio of 269, Dividend Yield of 0.0 or Days Sales Outstanding of 299. Cytokinetics financial statements analysis is a perfect complement when working with Cytokinetics Valuation or Volatility modules.
Cytokinetics | Operating Cycle | Build AI portfolio with Cytokinetics Stock |
Historical Operating Cycle data for Cytokinetics serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Cytokinetics represents a compelling investment opportunity.
Latest Cytokinetics' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Cytokinetics over the last few years. It is Cytokinetics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytokinetics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Cytokinetics Operating Cycle Regression Statistics
| Arithmetic Mean | 110.65 | |
| Geometric Mean | 9.44 | |
| Coefficient Of Variation | 133.35 | |
| Mean Deviation | 127.36 | |
| Median | 30.36 | |
| Standard Deviation | 147.56 | |
| Sample Variance | 21,773 | |
| Range | 378 | |
| R-Value | 0.57 | |
| Mean Square Error | 15,779 | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 16.55 | |
| Total Sum of Squares | 348,366 |
Cytokinetics Operating Cycle History
About Cytokinetics Financial Statements
Cytokinetics investors utilize fundamental indicators, such as Operating Cycle, to predict how Cytokinetics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 378.31 | 297.25 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Cytokinetics Correlation against competitors. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.30) | Revenue Per Share | Quarterly Revenue Growth 3.181 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.